These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9124210)

  • 21. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
    Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
    Quintanilla-Martinez L; Kumar S; Fend F; Reyes E; Teruya-Feldstein J; Kingma DW; Sorbara L; Raffeld M; Straus SE; Jaffe ES
    Blood; 2000 Jul; 96(2):443-51. PubMed ID: 10887104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma.
    Shiozawa E; Saito B; Yamochi-Onizuka T; Makino R; Takimoto M; Nakamaki T; Tomoyasu S; Ota H
    Pathol Int; 2007 Oct; 57(10):688-93. PubMed ID: 17803658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathologic study of post-transplant lymphoproliferative disorders].
    Zhang YN; Zhou XG; Wang CZ; Wei P; Zhang SH; Zheng YY
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):209-12. PubMed ID: 16776977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologically discordant lymphomas with B-cell and T-cell components.
    Abruzzo LV; Griffith LM; Nandedkar M; Aguilera NS; Taubenberger JK; Raffeld M; Stass SA; Abbondanzo SL; Jaffe ES
    Am J Clin Pathol; 1997 Sep; 108(3):316-23. PubMed ID: 9291461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
    Chadburn A; Suciu-Foca N; Cesarman E; Reed E; Michler RE; Knowles DM
    Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas.
    Coad JE; Olson DJ; Christensen DR; Lander TA; Chibbar R; McGlennen RC; Brunning RD
    Am J Surg Pathol; 1997 Sep; 21(9):1047-56. PubMed ID: 9298881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring.
    Lones MA; Mishalani S; Shintaku IP; Weiss LM; Nichols WS; Said JW
    Hum Pathol; 1995 May; 26(5):525-30. PubMed ID: 7750936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria.
    Canioni D; Jabado N; MacIntyre E; Patey N; Emile JF; Brousse N
    Histopathology; 2001 Feb; 38(2):146-59. PubMed ID: 11207828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoproliferative disorders in renal transplant patients in Japan.
    Hoshida Y; Li T; Dong Z; Tomita Y; Yamauchi A; Hanai J; Aozasa K
    Int J Cancer; 2001 Mar; 91(6):869-75. PubMed ID: 11275994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature.
    Rockman SP
    Leukemia; 1997 Jun; 11(6):852-62. PubMed ID: 9177440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.
    Shapiro RS; McClain K; Frizzera G; Gajl-Peczalska KJ; Kersey JH; Blazar BR; Arthur DC; Patton DF; Greenberg JS; Burke B
    Blood; 1988 May; 71(5):1234-43. PubMed ID: 2833957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonality of primary pulmonary lymphoproliferative disorders; using in situ hybridization and polymerase chain reaction for immunoglobulin.
    Tashiro K; Ohshima K; Suzumiya J; Yoneda S; Yahiro M; Sugihara M; Shirakusa T; Kikuchi M
    Leuk Lymphoma; 1999 Dec; 36(1-2):157-67. PubMed ID: 10613461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of EBV-infected cells in donor marrow by counterflow elutriation.
    Gross TG; Hinrichs SH; Davis JR; Mitchell D; Bishop MR; Wagner JE
    Exp Hematol; 1998 May; 26(5):395-9. PubMed ID: 9590655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.
    Patton DF; Wilkowski CW; Hanson CA; Shapiro R; Gajl-Peczalska KJ; Filipovich AH; McClain KL
    Transplantation; 1990 Jun; 49(6):1080-4. PubMed ID: 2163133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes.
    Emanuel DJ; Lucas KG; Mallory GB; Edwards-Brown MK; Pollok KE; Conrad PD; Robertson KA; Smith FO
    Transplantation; 1997 Jun; 63(11):1691-4. PubMed ID: 9197369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation.
    Oda D; Persson GR; Haigh WG; Sabath DE; Penn I; Aziz S
    Transplantation; 1996 Feb; 61(3):435-40. PubMed ID: 8610357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.